4 Einträge gefunden

1. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus

   1. Kirtschig, G
   2. Cooper, S
   3. Aberer, W
   4. Günthert, A
   5. Becker, K
   6. Jasaitiene, D
   7. Chi, C-C

   2017 - Forschungsinformationssystem des UKE
2. EDF lichen sclerosus guideline Response

   1. Kirtschig, G
   2. Becker, K
   3. Günthert, A
   4. Jasaitiene, D
   5. Cooper, S M
   6. Chi, C-C
   7. Kreuter, A

   2017 - Forschungsinformationssystem des UKE
3. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

   1. Schilling, Georgia
   2. Bruweleit, Melanie
   3. Harbeck, N
   4. Thomssen, C
   5. Becker, K
   6. Hoffmann, R
   7. Villena, C

   2009 - Forschungsinformationssystem des UKE
4. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

   1. Köhne, C-H
   2. De Greve, J
   3. Hartmann, J T
   4. Lang, I
   5. Vergauwe, P
   6. Becker, K
   7. Braumann, D

   2008 - Forschungsinformationssystem des UKE